[Asia Economy Reporter Jang Hyowon] In the third week of this month (July), Saevitchem and HYTC will conduct demand forecasting for institutional investors. Seongil Hightech, ICH, April Bio, and Susan Industry are preparing for general subscription.



◆Saevitchem= Saevitchem is a specialized company in secondary battery recycling. Led by CEO Park Mingyu, the company has focused on eco-friendly recycling research and development, actively responding to high-nickel demand with high-purity refining technology and customer-tailored tuning technology. Last year, sales and operating profit were 33.4 billion KRW and 5.5 billion KRW respectively, with an operating profit margin of 16.5%.


The total number of shares offered is 1.07 million, with a desired public offering price band of 25,000 to 30,000 KRW, making the total public offering amount approximately 26.8 to 32.1 billion KRW. Demand forecasting will be conducted on the 20th and 21st to finalize the public offering price, followed by subscription on the 26th and 27th, aiming for a KOSDAQ listing within August. The lead underwriter is Korea Investment & Securities.


◆HYTC= Established in 2005, HYTC primarily manufactures ultra-precision parts for secondary battery manufacturing equipment. It produces ultra-precision parts used in most equipment for electrode plate and assembly processes, excluding the chemical process in secondary battery manufacturing, and is expanding its product range through continuous technology development.


The total number of shares offered is 2.26 million, with a desired public offering price range of 13,000 to 15,000 KRW per share, and the expected public offering amount is 29.4 to 33.9 billion KRW. Demand forecasting will be conducted on the 21st and 22nd to finalize the public offering price, followed by general subscription on the 28th and 29th of the same month. The listing is scheduled for August, with Shin Young Securities as the lead underwriter.



◆Seongil Hightech= Seongil Hightech recorded a competition rate of 2,269.7 to 1 in demand forecasting and finalized the public offering price at 50,000 KRW, exceeding the upper limit of the desired price. The general public subscription will be held over two days on the 18th and 19th. The lead underwriters are KB Securities and Daishin Securities, with Samsung Securities participating as the underwriting company. The scheduled listing date is the 28th of this month.


Seongil Hightech is an eco-friendly secondary battery recycling specialized company that extracts valuable metals from secondary batteries used in electric vehicles, mobile phones, laptops, energy storage systems (ESS), and power tools. It is the only company in Korea that possesses an integrated secondary battery recycling process and produces the highest quality secondary battery materials on the largest scale domestically through the advancement of wet smelting technology.


◆ICH= ICH conducted demand forecasting for institutional investors on the 13th and 14th. The total number of shares offered is 1.18 million, with a proposed public offering price band of 34,000 to 44,000 KRW. General subscription will be held on the 19th and 20th, with a planned KOSDAQ listing within this month. The lead underwriter is Samsung Securities.


The company owns the ‘room temperature press patterning process,’ an antenna manufacturing process. It implements precise antenna circuits solely by press methods at room temperature without applying heat. The three main products driving ICH’s performance are adhesive tapes for IT devices, electromagnetic shielding gaskets, and film-type thin antennas (MFA, Metal Foil Antenna).


◆April Bio= April Bio conducted demand forecasting for institutional investors on the 13th and 14th. The total number of shares offered is 1.62 million, with an expected public offering price of 20,000 to 23,000 KRW. General subscription will be held on the 19th and 20th, with a planned KOSDAQ listing on the 28th. The underwriter is NH Investment & Securities.


Founded in 2013, April Bio is a protein (antibody) therapeutic development company targeting autoimmune diseases, inflammatory diseases, and cancer by utilizing the platform technology ‘SAFA (Anti-Serum Albumin Fab),’ which extends the half-life of drugs (the time it takes for the drug concentration to reduce to half from its peak), and the ‘antibody library’ (HuDVFab, Human naive Fab antibody library) technology that discovers antibodies matching target antigens.


◆Susan Industry= Susan Industry conducted demand forecasting on the 14th and 15th. The total number of shares offered is 5.715 million, with a desired public offering price band of 35,000 to 43,100 KRW per share. General subscription will be held on the 20th and 21st. The listing is scheduled for the end of this month, with Samsung Securities as the lead underwriter.


Established in 1983, Susan Industry provides comprehensive maintenance services for major nuclear, thermal, and renewable power plants, improving equipment operation rates and preventing unexpected shutdowns at various power plants. According to last year’s consolidated financials, sales proportions were 48.7% nuclear, 31.1% thermal, 10.8% renewable, and 9.4% others.





This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing